Alyeska Investment Group
APVO icon

Alyeska Investment Group’s Aptevo Therapeutics APVO Stock Holding History

Alyeska Investment Group’s Portfolio APVO Stock Details APVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Hold
0
– – – 473
2023
Q4 		– Hold
0
– – – 530
2021
Q3 		– Hold
0
– -$3.12M – 680
2021
Q2 		– Hold
0
– – – 434
2021
Q1 		– Hold
0
– – – 424
2020
Q4 		– Hold
0
– – – 378
2020
Q3 		– Hold
0
– – – 461
2020
Q2 		– Hold
0
– – – 475
2020
Q1 		– Hold
0
– – – 373
2019
Q4 		– Hold
0
– – – 409
2019
Q3 		– Hold
0
– – – 404
2019
Q2 		– Hold
0
– – – 420
2019
Q1 		– Hold
0
– – – 335

Other funds holding APVO

TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
TC
Truvestments Capital Sarasota, Florida $554M AUM 32.49% 1-Year Est. Return